In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens

Asian Pacific Journal of Tropical Medicine

Volumn 6, Issue 5, 2013, Pages 352-359

  Kamruzzaman, Muhammad ^a   Bari, S M Nayeemul ^a   Faruque, Shah M ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Bactericidal activity; Enteric pathogenic bacteria; Vitex negundo

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; METHANOL; NALIDIXIC ACID; PLANT EXTRACT; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VIVEX NEGUNDO EXTRACT; WATER;

AEROMONAS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; CELL COUNT; CELL VIABILITY; CHOLERA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISK DIFFUSION; DOSE RESPONSE; DRUG DOSE COMPARISON; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; MALE; MICROBIAL DIVERSITY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; RISK REDUCTION; SHIGELLA; SOLVENT EXTRACTION; SURVIVAL RATE; VERBENACEAE; VIBRIO CHOLERAE; VIBRIO MIMICUS; VIBRIO PARAHAEMOLYTICUS; VIVEX NEGUNDO;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; INTESTINES; MALE; METHANOL; MICE; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PLANT LEAVES; SURVIVAL ANALYSIS; VIBRIO INFECTIONS; VITEX;

EID: 84876714749     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(13)60038-3     Document Type: Article

References (53)

1. Bax R, Mullan N, Verhoef J The millennium bugs the need for and development of new antibacterials. Int J Antimicrob Agents 2000, 16:51-59.
2. Saha D, Karim MM, Khan WA, Ahmed S, Salam MA, Bennish ML Single dose azithromycin for the treatment of cholera in adults. N Engl J Med 2006, 354:2452-2462.
3. Faruque ASG, Alam K, Malek MA, Khan GY, Ahmed S, Saha D, et al. Emergence of multi-drug resistant strain of V. cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after 2 years. J Health Popul Nutr 2007, 25:241-243.
4. Mwansa JC, Mwaba J, Lukwesa C, Bhuiyan NA, Ansaruzzaman M, Ramamurthy T, et al. Multiply antibiotic-resistant V. cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia. Epidemiol Infect 2007, 135:847-853.
5. Islam MS, Mahmud ZH, Ansaruzzaman M, Faruque SM, Talukder KA, Qadri F, et al. Phenotypic, genotyping and antibiotic sensitivity of strains isolated from cholera epidemic in Zimbabwe. J Clin Microbiol 2011, 49:2325-2327.
6. Levy SB, Marshall B Antibacterial resistant worldwide: causes, challenges and responses. Nat Med Suppl 2004, 10:S122-S129.
7. Cowan MM Plant products as antimicrobial agents. Clin Microbiol Rev 1999, 12:564-582.
8. Heinrich M, Barnes J, Gibbons S, Williamson EM Fundamentals of pharmacognosy and phytotherapy 2004, 4-7. Churchill Livingstone, Edinburgh.
9. Iwu MW, Duncan AR, Okunji CO New antimicrobials of plant origin. Perspectives on new crops and new uses 1999, 457-462. ASHS Press, Alexandria, VA. J. Janick (Ed.).
10. Lal S, Jain S, Prakash O, Jain N Shambhalu: An important medicinal plant. J Pharm Sci 2006, 7:45-55.
11. Dharmasiri MG, Jayakody JR, Galhena G, Liyanage SS, Ratnasooriya WD Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo. J Ethnopharmacol 2003, 87:199-206.
12. Chawla AS, Sharma AK, Handa SS, Dhar KL Chemical investigation and anti-inflammatory activity of Vitex negundo seeds. J Nat Prod 1992, 55:163-167.
13. Nagarsekar KS, Nagarsenker MS, Kulkarni SR Evaluation of composition and antimicrobial activity of supercritical fluid extract of leaves of Vitex negundo. Indian J Pharm Sci 2010, 72:641-643.
14. Taneja SC, Gupta RK, Dhar KL, Atal CK The essential oil of Vitex negundo Linn. Indian Perfumer 1979, 22:162.
15. Khokra SL, Prakash O, Jain S, Aneja KR, Dhingra Y Essential oil composition and antibacterial studies of Vitex negundo Linn extracts. Indian J Pharm Sci 2008, 70:522-526.
16. Rasaga CY, Morales E, Rideout JA Antimicrobial compounds from Vitex negundo. Philippine J Sci 1999, 128:21-29.
17. Uddin SN, Rahman MM Traditional uses of ethnomedicinal plants of the Chittagong hill tracts 2006, National Herberium, Bangladesh.
18. Dey TK. Useful plants of Bangladesh. 1995.
19. Bauer AW, Kirby WM, Sherris JC, Turck M Antibiotic susceptibility testing by a standardized single disk method. Am J Clin pathol 1966, 45:493-496.
20. Ericsson HM, Sherris JC Antibiotic sensitivity testing report of an international collaborative study. Acta Pathol Microbiol Scand 1971, 217:1-90.
21. Suffredini IB, Sader HS, Goncalves AG, Reis AO, Gales AC, Varella AD, et al. Screening of antibacterial activity extracts obtained from plants native to Brazilian amazon rain forest. Braz J Med Ethnopharmacol 2004, 62:183-193.
22. Toda M, Okubo S, Hiyoshi R, Shimamura T The bactericidal activity of tea and coffee. Lett Appl Microbiol 1989, 8:123-125.
23. Gardel CL, Mekalanos JJ Alterations in V. cholerae motility phenotypes correlate with changes in virulence factor expression. Infect Immun 1996, 64:2246-2255.
24. Nishibuchi M, Seidler RJ, Rollins DM, Joseph SW Vibrio factors cause rapid fluid accumulation in suckling mice. Infect Immun 1983, 40:1083-1091.
25. Faruque SM, Albert MJ, Mekalanos JJ Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev 1998, 62:1301-1314.
26. Morris JG, Black RE Cholera and other vibrios in the United States. N Engl J Med 1985, 312:343-350.
27. Janda JM, Powers C, Bryant RG, Abbott SL Current perspective on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin Microbiol Rev 1988, 1:245-267.
28. Ramamurthy T, Albert MJ, Huq A, Colwell RR, Takeda Y, Takeda T, et al. Vibrio mimicus with multiple toxin types isolated from human and environmental sources. J Med Microbiol 1994, 40:194-196.
29. Spira WM, Fedorka-Cray PJ Purification of enterotoxins from Vibrio mimicus that appear to be identical to cholera toxin. Infect Immun 1984, 45:679-684.
30. Okuda J, Ishibashi M, Hayakawa E, Nishino T, Takeda Y, Mukhopadhyay AK, et al. Emergence of a unique O3: K6 clone of Vibrio parahaemolyticus in Calcutta, India, and isolation of strains from the same clonal group from Southeast Asian travelers arriving in Japan. J Clin Microbiol 1997, 35:3150-3155.
31. Matsumoto C, Okuda J, Ishibashi M, Iwanaga M, Garg P, Rammamurthy T, et al. Pandemic spread of an O3: K6 clone of Vibrio parahaemolyticus and emergence of related strains evidenced by arbitrarily primed PCR and toxRS sequence analyses. J Clin Microbiol 2000, 38:578-585.
32. Nishioka T, Kamruzzaman M, Nishibuchi M, Satta Y On the origin and function of an insertion element VpaI1 specific to post 1995, pandemic V. parahaemolyticus strains. Genes Genet Syst 2008, 83:101-110.
33. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999, 5:607-625.
34. Kaper JB, Nataro JP, Mobley HL Pathogenic Escherichia coli. Nat Rev Microbiol 2004, 2:123-140.
35. Nataro JP, Kaper JB Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998, 11:142-201.
36. Fukushima H, Hashizume T, Morita Y, Tanaka J, Azuma K, Mizumoto Y, et al. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996. Pediat Int 1999, 41:213-217.
37. Chen LC, Rahman M, Sarder AM Epidemiology and causes of death among children in a rural area of Bangladesh. Int J Epidemiol 1980, 9:25-33.
38. Ronsmans C, Bennish ML, Wierzba T Diagnosis and management of dysentery by community health workers. Lancet 1988, 2:552-555.
39. Zaidan MR, Noor RA, Badrul AR, Adlin A, Norazah A, Zakiah I In vitro screening of five local medicinal plants for antibacterial activity using disc diffusion method. Trop Biomed 2005, 22:165-170.
40. Perumal SR, Ignacimuthu S, Sen A Screening of 34 Indian medicinal plants for antibacterial properties. J Ethnopharmacol 1998, 62:173-182.
41. Kannathasan K, Senthilkumar A, Chandrasekaran M, Venkatesalu V Differential larvicidal efficacy of four species of Vitex against Culex quinquefasciatus larvae. Parasitol Res 2007, 101:1721-1723.
42. Sathiamoorthy B, Gupta P, Kumar M, Chaturvedi AK, Shukla PK, Maurya R New antifungal flavonoid glycoside from Vitex negundo. Bioorg Med Chem Lett 2007, 17:239-242.
43. Kulkarni RR, Virkar AD, Dmello P Antioxidant and antiinflammatory activity of Vitex negundo. Indian J Pharm Sci 2008, 70:838-840.
44. Vinuchakkaravarthy T, Kumaravel KP, Ravichandran S, Velmurugan D Active compound from the leaves of Vitex negundo L. shows anti-inflammatory activity with evidence of inhibition for secretory Phospholipase A(2) through molecular docking. Bioinformation 2011, 7:199-206.
45. Zheng CJ, Huang BK, Wang Y, Ye Q, Han T, Zhang QY, et al. Anti-inflammatory diterpenes from the seeds of Vitex negundo. Bioorg Med Chem 2010, 18:175-181.
46. Tandon VR, Khajuria V, Kapoor B, Kour D, Gupta S Hepatoprotective activity of Vitex negundo leaf extract against anti-tubercular drugs induced hepatotoxicity. Fitoterapia 2008, 79:533-538.
47. Rahman MA, Islam MS Antioxidant, antibacterial and cytotoxic effects of the phytochemicals of whole Leucas aspera extract. Asian Pac J Trop Biomed 2013, 3(4):273-279.
48. Arokiyaraj S, Sripriya N, Bhagya R, Radhika B, Prameela L, Udayaprakash NK Phytochemical screening, antibacterial and free radical scavenging effects of Artemisia nilagirica, Mimosa pudica and Clerodendrum siphonanthus-An in-vitro study. Asian Pac J Trop Biomed 2012, 2(Suppl 2):S601-S604.
49. Sahu MC, Padhy RN In vitro antibacterial potency of Butea monosperma Lam. against 12 clinically isolated multidrug resistant bacteria. Asian Pac J Trop Dis 2013, 3(3):217-226.
50. Devi PR, Kokilavani R, Poongothai SG Anti microbial activity of the various leaf extracts of Vitex negundo Linn. Anc Sci Life 2008, 27:22-27.
51. Parekh J, Karathia N, Chanda S Screening of some traditionally used medicinal plants for potential antibacterial activity. Indian J Pharm Sci 2006, 68:832-834.
52. Sawer IK, Berry MI, Ford JL Effect of medium composition, agitation and presence of EDTA on the antimicrobial activity of cryptolepine. Lett Appl Microbiol 1997, 25:207-211.
53. Gao Y, Belkum MJV, Stiles M The outer membrane of Gram-negative bacteria inhibits antibacterial activity of brochocin C. Appl Environ Microb 1999, 65:4329-4333.